ABEMACICLIB, A SELECTIVE CDK4/6 INHIBITOR, RESTRICTS GROWTH OF PEDIATRIC GLIAL-LINEAGE TUMORS IN VITRO AND IN VIVO

被引：0

作者：

Liang, Muh-Lii ^{[1
]}

Hsieh, Tsung-Han ^{[2
]}

Wong, Tai-Tong ^{[3
]}

机构：

[1] Mackay Mem Hosp, Dept Neurosurg, Taipei, Taiwan

[2] Taipei Med Univ, Off Human Res, Joint Biobank, Taipei, Taiwan

[3] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MODL-16

引用

页码：414 / 414

页数：1

共 50 条

[1] Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas
Liang, Muh-Lii
Chen, Chun-Han
Liu, Yun-Ru
Huang, Man-Hsu
Lin, Yu-Chen
Wong, Tai-Tong
Lin, Sey-En
Chu, Shing-Shiung
Ding, Yi-Huei
Hsieh, Tsung-Han
CANCERS, 2020, 12 (12) : 1 - 17
[2] Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non-Small Cell Lung Cancer In Vitro and In Vivo
Naz, Sarwat
Sowers, Anastasia
Choudhuri, Rajani
Wissler, Maria
Gamson, Janet
Mathias, Askale
Cook, John A.
Mitchell, James B.
CLINICAL CANCER RESEARCH, 2018, 24 (16) : 3994 - 4005
[3] The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib
Gong Xueqian
Chio, Li-Chun
Webster, Yue
Lallena, Maria Jose
Boehnke, Karsten
Torres, Raquel
Iversen, Phil
De Dios, Alfonso
Smith, Ian
Reinhard, Christoph
Peng, Sheng-Bin
Dempsey, Jack
Burke, Teresa
Chen, Shih-Hsun
Stewart, Trent
Beckmann, Richard
Wu, Wenjuan
Buchanan, Sean G.
MOLECULAR CANCER RESEARCH, 2016, 14
[4] Targeting prostate cancer with the CDK4 and CDK6 inhibitor abemaciclib
Torres-Guzman, Raquel
Baquero, Carmen
Patricia Ganado, Maria
Marugan, Carlos
Bian, Huimin
Zeng, Yi
Rama, Ramon
Du, Jian
Jose Lallena, Maria
CANCER RESEARCH, 2020, 80 (16)
[5] THE CDK4/6 INHIBITOR ABEMACICLIB IN PATIENTS WITH RECURRENT MENINGIOMA AND OTHER PRIMARY CNS TUMORS
Coffee, Elizabeth
Panageas, Katherine
Young, Robert
Morrison, Tara
Daher, Ahmad
Grommes, Christian
Gavrilovic, Igor T.
Lin, Andrew
Miller, Alexandra
Schaff, Lauren
Daras, Mariza
DeAngelis, Lisa
Diamond, Eli
Piotrowski, Anna
Malani, Rachna
Nolan, Craig
Pentsova, Elena
Santomasso, Bianca
Stone, Jacqueline
Nair, Suresh
Mellinghoff, Ingo K.
Kaley, Thomas
NEURO-ONCOLOGY, 2021, 23 : 72 - 73
[6] Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer
Palumbo, Alison
Lau, Gary
Saraceni, Megan
ANNALS OF PHARMACOTHERAPY, 2019, 53 (02) : 178 - 185
[7] Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
Martin, Miguel
Garcia-Saenz, Jose A.
Manso, Luis
Llombart, Antonio
Cassinello, Alejo
Atienza, Manuel
Ringeisen, Francois
Ciruelos, Eva
FUTURE ONCOLOGY, 2020, 16 (33) : 2763 - 2778
[8] Biological characterization of 2-aminothiazole-derived Cdk4/6 selective inhibitor in vitro and in vivo
Hirai, Hiroshi
Shimomura, Toshiyasu
Kobayashi, Makiko
Eguchi, Tomohiro
Taniguchi, Eri
Fukasawa, Kazuhiro
Machida, Takumitsu
Oki, Hiroko
Arai, Tsuyoshi
Ichikawa, Koji
Hasako, Shinichi
Haze, Kyosuke
Kodera, Tsutomu
Kawanishi, Nobuhiko
Takahashi-Suziki, Ikuko
Nakatsuru, Yoko
Kotani, Hidehito
Iwasawa, Yoshikazu
CELL CYCLE, 2010, 9 (08) : 1590 - 1600
[9] CDK4 & 6 inhibitor Abemaciclib exerts intrinsic immunomodulatory effects on human T cells in vitro
Chin, Darin
Carpenito, Carmine
Amaladas, Nelusha
Chung, Linda
Staschke, Kirk
Schaer, David
Beckmann, Richard
Novosiadly, Ruslan
Kalos, Michael
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[10] Lysosome-targeted cytocidal effect of CDK4/6 inhibitor abemaciclib
Hino, Hirotsugu
Kazama, Hiromi
Moriya, Shota
Takano, Naoharu
Hiramoto, Masaki
Miyazawa, Keisuke
CANCER SCIENCE, 2018, 109 : 1026 - 1026

← 1 2 3 4 5 →